For treatment of: Furazolidone pneumonia, amoebiasis, peritonitis, endometritis, colitis, abscesses, empyema, trichomoniasis, infections caused by Bacteroides spp., infections caused by Clostridium spp., Peptococcus spp., Peptostreptococcus spp., prevention of postoperative complications, protozoal infections, H. pylori eradication, extra-intestinal amoebiasis.Furazolidone
- For the treatment of internal organs: antimicrobial and Antiprotozoal agents.
- Appointment: giardiasis, dysentery, treatment of food toxicoinfections (PTI)
- Indications for use:
— food toxic infection.
— pregnancy, lactation;
— increased individual sensitivity to the group of nitrofurans;
— end-stage chronic kidney failure;
— glucose-6-phosphate dehydrogenase deficiency;
— children under 3 years of age (for this dosage form).
Chronic renal failure, glucose-6 - phosphate dehydrogenase deficiency, liver and nervous system diseases .
furazolidone - 50 mg.
Excipients: potato starch - 20 mg, calcium stearate (calcium stearic acid) - 1 mg, sugar (sucrose) - 10 mg, twin-80 (Polysorbate) - 0.2 mg, lactose (milk sugar) - 18.8 mg.
- Manufacturer: Bronnitsky plant of medical products